Correlation Engine 2.0
Clear Search sequence regions

  • analysis periods (1)
  • argentina (2)
  • brain (1)
  • fibrinolysis (7)
  • humans (1)
  • ischemia (1)
  • patients (6)
  • plasminogen (2)
  • stroke (12)
  • Sizes of these terms reflect their relevance to your search.

    Intravenous fibrinolysis with recombinant tissue plasminogen activator (rTPA) and use of stroke units improve morbidity and mortality in patients with acute ischemic stroke (AIS). However, data published in Argentina are scarce. We describe the experience in the use of fibrinolysis in patients with acute ischemic stroke (AIS) before and after the implementation of a stroke unit in a Comprehensive Stroke Center in Buenos Aires during the last 17 years. Retrospective analysis of consecutive patients treated with rTPA between January 2003 and December 2019. Treatment times, hospitalization time, post-treatment complications and disability at 3 months were evaluated. For the analysis, the pre and post opening periods of the stroke unit were evaluated, Period 1 (P1, from 2003 to 2011) and Period 2 (P2, from 2012 to 2019). Intravenous fibrinolysis was performed in 182 patients. Opening of the stroke unit resulted in an increase in the percentage of fibrinolysis over the total number of admitted strokes (4% in P1 vs. 10% in P2, p < 0.001), shortening of the door-to-needle time (75 minutes in P1 vs. 53 minutes in P2, p < 0.00001) and higher proportion of patients treated within 60 minutes of hospital admission (36% in P1 vs. 76% in P2, p < 0.00001). In addition, there was a reduction in the median hospital stay from 9 days in P1 to 5 days in P2 (p < 0.00001). In conclusion, stroke units seem to optimize the use of fibrinolysis in acute stroke, increasing the percentage of patients treated, reducing door-to-needle time, and reducing hospitalization time.


    Julieta S Rosales, Federico Rodriguez Lucci, Sebastián F Ameriso. Use and results of intravenous fibrinolysis in a stroke unit]. Medicina. 2021;81(1):6-10

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33611238

    View Full Text